Cargando…
Host CD73 impairs anti-tumor immunity
The enzymatic activity of CD73 produces immune-suppressing adenosine. In CD73 deficient hosts, tumor growth and tumor infiltration by Tregs and type 2 immunosuppressive macrophages is reduced. Pharmacological inhibition of CD73 in wild-type mice has similar tumor-suppressing effects. Host CD73 on le...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376983/ https://www.ncbi.nlm.nih.gov/pubmed/22720259 http://dx.doi.org/10.4161/onci.1.2.18310 |
_version_ | 1782235896089673728 |
---|---|
author | Salmi, Marko Jalkanen, Sirpa |
author_facet | Salmi, Marko Jalkanen, Sirpa |
author_sort | Salmi, Marko |
collection | PubMed |
description | The enzymatic activity of CD73 produces immune-suppressing adenosine. In CD73 deficient hosts, tumor growth and tumor infiltration by Tregs and type 2 immunosuppressive macrophages is reduced. Pharmacological inhibition of CD73 in wild-type mice has similar tumor-suppressing effects. Host CD73 on leukocytes and endothelial cells is thus detrimental for the anti-tumor immunity. |
format | Online Article Text |
id | pubmed-3376983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-33769832012-06-20 Host CD73 impairs anti-tumor immunity Salmi, Marko Jalkanen, Sirpa Oncoimmunology Author's View The enzymatic activity of CD73 produces immune-suppressing adenosine. In CD73 deficient hosts, tumor growth and tumor infiltration by Tregs and type 2 immunosuppressive macrophages is reduced. Pharmacological inhibition of CD73 in wild-type mice has similar tumor-suppressing effects. Host CD73 on leukocytes and endothelial cells is thus detrimental for the anti-tumor immunity. Landes Bioscience 2012-03-01 /pmc/articles/PMC3376983/ /pubmed/22720259 http://dx.doi.org/10.4161/onci.1.2.18310 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Salmi, Marko Jalkanen, Sirpa Host CD73 impairs anti-tumor immunity |
title | Host CD73 impairs anti-tumor immunity |
title_full | Host CD73 impairs anti-tumor immunity |
title_fullStr | Host CD73 impairs anti-tumor immunity |
title_full_unstemmed | Host CD73 impairs anti-tumor immunity |
title_short | Host CD73 impairs anti-tumor immunity |
title_sort | host cd73 impairs anti-tumor immunity |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376983/ https://www.ncbi.nlm.nih.gov/pubmed/22720259 http://dx.doi.org/10.4161/onci.1.2.18310 |
work_keys_str_mv | AT salmimarko hostcd73impairsantitumorimmunity AT jalkanensirpa hostcd73impairsantitumorimmunity |